Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$1.71B |
| 2 |
Eli Lilly
LLY
|
+$1.55B |
| 3 |
Tesla
TSLA
|
+$1.14B |
| 4 |
Boeing
BA
|
+$935M |
| 5 |
TE Connectivity
TEL
|
+$910M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.79B |
| 2 |
Visa
V
|
+$1.57B |
| 3 |
General Dynamics
GD
|
+$1.55B |
| 4 |
Morgan Stanley
MS
|
+$1.29B |
| 5 |
Exelon
EXC
|
+$1.15B |
Sector Composition
| 1 | Technology | 24.19% |
| 2 | Healthcare | 17.87% |
| 3 | Financials | 14.67% |
| 4 | Consumer Discretionary | 10.1% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CURB
1626
Curbline Properties Corp.
CURB
$2.36B
| $948K | ﹤0.01% |
+40,809
| New | +$948K |
|
1627
Absci
ABSI
$381M
| $924K | ﹤0.01% |
352,805
+3,951
| +1% | +$10.4K |
|
|
EBTC
1628
DELISTED
Enterprise Bancorp
EBTC
| $923K | ﹤0.01% |
23,333
-40,590
| -63% | -$1.6M |
|
1629
MeiraGTx Holdings
MGTX
$612M
| $920K | ﹤0.01% |
151,126
+1,379
| +0.9% | +$8.4K |
|
|
CNCK
1630
Coincheck Group N.V. Ordinary Shares
CNCK
$645M
| $911K | ﹤0.01% |
+102,451
| New | +$911K |
|
1631
Dyne Therapeutics
DYN
$1.87B
| $908K | ﹤0.01% |
38,550
-3,111
| -7% | -$73.3K |
|
1632
Descartes Systems
DSGX
$8.96B
| $904K | ﹤0.01% |
7,957
+438
| +6% | +$49.8K |
|
|
JNPR
1633
DELISTED
Juniper Networks
JNPR
| $887K | ﹤0.01% |
23,672
+1,852
| +8% | +$69.4K |
|
1634
Beam Therapeutics
BEAM
$2.08B
| $882K | ﹤0.01% |
35,569
-3,427
| -9% | -$85K |
|
1635
AnaptysBio
ANAB
$655M
| $880K | ﹤0.01% |
66,467
+528
| +0.8% | +$6.99K |
|
1636
Iovance Biotherapeutics
IOVA
$821M
| $869K | ﹤0.01% |
117,426
-12,056
| -9% | -$89.2K |
|
1637
Ameriprise Financial
AMP
$46.9B
| $866K | ﹤0.01% |
1,627
+261
| +19% | +$139K |
|
|
THRD
1638
DELISTED
Third Harmonic Bio
THRD
| $858K | ﹤0.01% |
83,392
+6,022
| +8% | +$62K |
|
1639
Supernus Pharmaceuticals
SUPN
$2.55B
| $850K | ﹤0.01% |
23,500
-2,826
| -11% | -$102K |
|
1640
Viatris
VTRS
$11.6B
| $848K | ﹤0.01% |
68,148
+6,274
| +10% | +$78.1K |
|
|
ITOS
1641
DELISTED
iTeos Therapeutics
ITOS
| $847K | ﹤0.01% |
110,332
+4,563
| +4% | +$35K |
|
1642
Agios Pharmaceuticals
AGIO
$2.14B
| $838K | ﹤0.01% |
25,489
-3,959
| -13% | -$130K |
|
1643
Afya
AFYA
$1.42B
| $829K | ﹤0.01% |
+52,203
| New | +$829K |
|
1644
Weatherford International
WFRD
$4.48B
| $826K | ﹤0.01% |
11,537
-143,678
| -93% | -$10.3M |
|
1645
Mersana Therapeutics
MRSN
$35.6M
| $824K | ﹤0.01% |
23,046
-1,686
| -7% | -$60.3K |
|
1646
Celcuity
CELC
$2.33B
| $822K | ﹤0.01% |
62,776
+11,165
| +22% | +$146K |
|
1647
Ligand Pharmaceuticals
LGND
$3.23B
| $815K | ﹤0.01% |
7,603
-1,085
| -12% | -$116K |
|
|
LENZ
1648
LENZ Therapeutics
LENZ
$1.18B
| $815K | ﹤0.01% |
28,216
+3,595
| +15% | +$104K |
|
1649
Organogenesis Holdings
ORGO
$625M
| $814K | ﹤0.01% |
254,282
+12,634
| +5% | +$40.4K |
|
1650
Fulcrum Therapeutics
FULC
$379M
| $809K | ﹤0.01% |
172,158
-4,003
| -2% | -$18.8K |
|